The Ministry of Health (MoH) alerted members of the public to a health product and a cosmetic product which have been tested by the Laboratory of Pharmacy Section, Department of Scientific Services, MoH and found to be adulterated with undeclared, potent western medicine.
The health product is Hickel Mass and Strength Sachet, manufactured by Symposium Healthtech Ltd, UK, adulterated with Tadalafil.
The cosmetic product is Erase Whitening Lotion SPF 50, manufactured by F&H Ent South Kuala Lumpur, adulterated with Tretinoin.
The adulterant can cause adverse effects that are potentially hazardous to the people using them.
Tadalafil is a drug used to treat male impotency and can only be prescribed by a qualified doctor or physician. The side effects include nausea, vomiting, flushing and dizziness. In severe cases, it can also result in abnormal increase in heart rate, sudden loss of hearing and seizures.
Tretinoin is a potent ingredient used in western prescription medicines to treat skin conditions and is prohibited in skincare cosmetic products under the Medicines (Cosmetic Products) Regulations. Inappropriate use of tretinoin could lead to redness, peeling and scarring of the skin.
The MoH has withdrawn the Cosmetic Notification Acknowledgement Letter for the cosmetic product.
The products are not allowed to be imported and sold in Brunei Darussalam.
Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.
Members of the public involved in the retail of these products, including online retail are reminded that it is an offence under the Medicines (Cosmetic Products) Regulations, 2007 to import and market cosmetic products in the local market without a Cosmetic Product Notification Acknowledgement Letter issued by the authority. The penalty for contravening these regulations upon conviction, is a fine not exceeding BND5,000, imprisonment for a term not exceeding two years or both.
The ministry called upon the public for cooperation to report to the Compliance and Licensing Section if any of these products are still found in the Brunei market.
The public can contact the Compliance and Licensing Section at 2393298, extension 208; send an e-mail to [email protected]; go directly to the first floor, Compliance and Licensing Section, Department of Pharmaceutical Services’ Building, Kampong Madaras, Mukim Gadong ‘A’; or call Darussalam hotline 123.